Kite Pharma gets good news on lymphoma treatment

CNBC's Meg Tirrell reports on Kite Pharma's positive clinical trial results following lymphoma treatment, as well as the latest controversy surrounding Mylan's EpiPen price hike and CEO Heather Bresch's congressional testimony.